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Cell-matrix interactions in the glomerular mesangium. Specific inter-
actions between cells and components of the surrounding extracdllular
matrix (ECM) or underlying basement membrane have been shown to
modulate cell behavior, including cellular responses to soluble regulator
molecules. In addition to the long-recognized role of such interactions in
cell localization, anchoring and differentiation during embryogenesis, they
are also involved in diverse processes such as maintenance of tissue
integrity, response of cells to mechanical stress, inflammatory response,
wound healing, tumor cell growth and metastasis as well as apoptosis.
Over the last several years, evidence has been reported that extensive
"cross-talk" between glomerular mesangial cells (MC5), ECM molecules
and soluble mediator substances also affects the proliferative and synthetic
phenotype of MCs. This is likely to be relevant for the behavior of MCs
during embryonic development, tissue repair and disease processes of
glomeruli. The potential biologic and clinical relevance of cell-matrix
interactions in the glomerulus makes their elucidation a challenging goal
in current kidney research. In this brief review, we present selected aspects
of recent investigations concerning the mesangial matrix and its interac-
tions with MCs. In addition to results from cell culture studies, descriptive
findings on abnormalities of the ECM and their potential role for the
altered MC behavior in glomerular disease will also be discussed.
Mesangial matrix: Composition and turnover
In the mammalian kidney, the mesangium represents the
interstitial space of the glomerular capillary tuft, being restricted
to a centrolobular or axial, that is, mesangial localization. Thus,
the non-polarized MCs, which are surrounded by ECM, can be
considered specialized connective tissue cells. Because of their
location and vascular smooth muscle-like phenotype, including
contractility, MCs have also properties shared with vascular
pericytes and myofibroblasts. MCs in culture and in vivo have
been shown to readily produce ECM. Amount and composition of
the mesangial ECM are determinants of the structural and
functional properties of the glomerulus. Table 1 summarizes the
synthetic profile of MCs with regard to ECM molecules in culture
and in models of glomerular disease. Under normal conditions,
the ECM compounds are continuously synthesized and degraded
in a tightly regulated manner, since the integrity of glomerular
matrices is strictly maintained throughout most of adult life. Loss
of this coordinated regulation leading to increase in mesangial
ECM deposition occurs in aging-associated changes of glomeruli
1] and in the development of glomerulosclerosis, a common
feature of chronic glomerular disease. The concept has been
proposed that the altered ECM of progressive glomerular scarring
affects the MC phenotype in an autocrine fashion with regard to
cell replication and further abnormal ECM synthesis, thus per-
petuating the glomerular disease [2].
Control of the biosynthetic activity of MC with regard to ECM
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production involves various soluble mediators, including cyto-
kines, such as TGF-13, TNF-cs, and PDGF, as well as hormones,
such as angiotensin II or arginine vasopressin (Table 1). Again,
the potential for autocrine and paracrine regulation exists because
TGF-/3 as well as PDGF can be secreted by MCs as well as by
recruited inflammatory cells.
ECM production is also regulated by metabolic factors. In MC
culture, high glucose concentrations have been shown to cause
accumulation of fibronectin, laminin, collagen IV and collagen VI,
but not collagen III [3]. Inconsistent data exist with regard to
collagen I expression [4]. Similarly, in human diabetic nodular
lesions of the glomerulus, increase in immunohistochemical stain-
ing of the mesangium was found for fibronectin, collagen IV and
heparan sulfate proteoglycan, whereas no collagen I and only little
collagen III staining was observed [5]. In addition to these first
descriptive studies, much more information is needed to under-
stand the dynamics and pathogenic relevance of ECM alterations
in diseased glomeruli.
ECM degradation is regulated by the activities of glomerular
neutral proteases and their specific inhibitors. Table 2 summarizes
main classes of matrix degrading enzymes, most of which have
also been identified in MCs [6]. For example, cultured MCs have
been shown to secrete plasminogen activator (PA) as well as its
inhibitor, PAl-i, which is deposited in the ECM [7]. TGF-13 was
found to inhibit PA and to increase PAl-i activity, possibly
leading to a net decrease in matrix degradation. Another well-
characterized ECM-degrading enzyme found in MCs is the 72
kDa collagenase. Its mesangial expression is regulated in an
unusual, tissue-specific fashion, in that TNF-a, PMA, IL-i and
cAMP-elevating agents raise its mRNA levels [8]. In MCs, TGF-/3
has also been observed to increase mRNA levels of the 72 kDa
collageriase as well as expression of its inhibitor, TIMP-1. Fur-
thermore, increased activity of this protease was demonstrated in
a rat model of immune-mediated glomerulonephritis (anti-Thy
1.1 nephritis), where a major increase in TGF-f3 and 72 kDa
collagenase was found to be strictly limited to the expanded
hypercellular mesangial area [9]. Similarly, in glomeruli of growth
hormone transgenic mice (bGH), a model of glomeruloscierosis,
72 kDa collagenase activity was observed to be elevated. No
TIMP-1 expression was found in control or bGH mice. Marti et al
identified another metalloproteinase, PUMP-i, which is secreted
by MCs and shows stromelysin-like activities.
With regard to the normal or abnormal ECM in vivo, it is
presently unclear to what extent matrix synthesis, ECM-degrading
enzymes and their inhibitors contribute to net mesangial matrix
deposition and abundance. However, changed activity of each
mechanism could potentially influence composition and amount
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Table 1. Extracellular matrix molecules synthesized by MC in culture and in vivo
in vivo/normal in vivo/diseased in vitro
Collagens
I — 'f'Thy1.i, PAN, renal ablation, TGF-f3 glom.
gene transfer
'fl'FCS
'f'-4JHG
III — 'PAN, TGF-13 glom. gene transfer 'f!'FCS
IV + 'fl'Thyl.i, PAN, GH transgenic, CSS,
mGvHD, renal ablation. TGF-/3 glom. gene
transfer, hum. diabetic nodules
'fl'TGF-/3, TXA2, HG
.Ll'PGE2
V +
VI + 'fl'mGvHD 'ftHG
VIII + +
Glycoproteins
Fibronectin + 'fl'Thyi.l, PAN, renal ablation, mGvHD, hum.
diabetic nodules
1)'TGF-13, HG, TXA2, Ang II, AVP, LDL
Nidogen/entactin + 'fl Thyi.1, renal ablation
Laminin + ')'Thy1.i, PAN, GH transgenic, renal ablation,
mGvHD
'fl'HG, FCS, TXA2
Tenascin + 'fl' in most types of human GN, whenever
there was expansion of ECM
+
Thrombospondin + +
Proteoglycans
Heparan sulfates + 'fl'Thyi.l, PAN, GH transgenic, renal ablation,
hum, diabetic nodules
'fl'-4J' HG
Chondroitin/dermatan sulfates + 'fl'Thyi.l, diabetic rats (STZ) 'if TGF-13, IL-i, TNF-a
(versican, decorin, biglycan) 'if-'lJ' HG
Abbreviations are: Thyl.1, anti-Thyl.1 nephritis; PAN, purine aminonucleoside nephrosis; CSS, chronic serum sickness; mGvHD, murine
graft-versus-host disease; GH, growth hormone; FCS, fetal calf serum; TXA2, thromboxane A2; HG, high glucose containing medium; TGF-p,
transforming growth factor beta; Ang II, angiotensin II; AVP, arginine vasopressin; LDL, low density lipoproteins; IL-i, interleukin-1; TNF-a, tumor
necrosis factor alpha.
Table 2. Mesangial matrix-degrading enzymes and their substrates
Enzyme Substrates
Serine proteases
plasminogen activators (PAs) glycoproteins, protein core
of proteoglycans, gelatin
Metalloproteinases (MMPs)
Interstitial collagenases type I, II, III, VII, X,
MMP-i (type I collagenase) collagens
Type IV collagenases gelatin, type IV, V, VII, X
MMP-2 (72kD collagenase) collagens, fibronectin
MMP-9 (92kD collagenase)
Stromelysins fibronectin, laminin,
MMP-3 (stromelysin-1, elastin, type IV, V, VIII,
proteoglycanase) IX collagens
MMP-7 (matrilysin, PUMP-i)
MMP-iO (stromelysin-2)
Cystein proteases (cathepsins) type I collagen, laminin,
proteoglycans
Endo-exoglycosidases GAGs and the aminosugar
moieties of proteoglycans
(See text for references)
of mesangial ECM affecting cell-matrix interactions and their
biological effects in the glomerulus. Better understanding of these
processes may have considerable diagnostic and therapeutic im-
plications in the management of giomerular disease.
Molecular mechanisms mediating cell-matrix interactions
Receptors
The molecular mechanisms of specific cell-ECM interactions
have only recently become amenable to thorough investigation.
Most cell types express transmembranous surface glycoproteins
Table 3. ECM receptor expression in the mesangiuma
Receptor Ligands
Human
Tissue Cells"
Rat
Tissue Cells"
/31-integrins
a, Col IV, Coil, LM + ++ ++ ++
02 ColI,CoIIV,LM + (+) (+) (+)0 LM, Col I, FN + + + +
a4 VCAM I, LM, FN - — - —
a5 FN,RGD + ++ + +
a6 LM (E8 fragment) — — — —
a7 LM ? ? ? ?
33-integrin
a,, VN, FN, RGD, multiple + + + +
Cell surface
proteoglycans
Syndecan 4 FN, Others? ? ? ? ?
a Detected by immunochemistiy
"Results dependent on the ECM substratum used for MC culture (see
text for references)
that specifically interact with ECM components. The widely
distributed integrins, a protein superfamily, permit cellular recog-
nition of ECM components. Receptors for ECM molecules also
include cell surface proteoglycans. Thus, various types of recep-
tors can specifically mediate attachment of cells to ECM mole-
cules and the effects of ECM on various cellular functions. A
summary of ECM receptor expression in the mesangium is given
in Table 3. Integrins are the best studied group of matrix
receptors. They are transmembrane, heterodimeric, non-cova-
lently associated protein complexes consisting of an a and a 13
chain. Integrins have been shown to control many cell-matrix
interactions, such as adhesion, growth and differentiation. The
ECM
2
Cell membrane
llIIllHllflhIillffiHI
Tensin
a
a-Actinin
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Fig. 1. Scheme of a focal contact. Focal
adhesion cell surface receptors, such as
integrins, recognize peptide motifs of proteins
of the extracellular matrix (ECM) and bind to a
complex of intracellular cytoskeletal proteins
which organize to form a focal contact. This
complex includes, such as talin, vinculin,
paxillin, tensin and n-actinin, building a link to
actin filaments. Transmission of integrin-
mediated signaling involves activation of focal
adhesion kinase (FAK). Signaling molecules
which associate with FAK include SH2-domain-
containing proteins, such as c-src tyrosine
kinase.
different distribution patterns of 31-integrins in the developing
and adult kidney imply their potential role in morphogenesis and
maintenance of the normal adult renal architecture. Cell surface
proteoglycans, especially the syndecan family and the cell surface
antigen CD44, have also been described to possess ECM receptor
qualities. Syndecans constitute a polymorphic family of cell sur-
face proteoglycans with variable glycosylation, bearing heparan
sulfate and chondroitin sulfate chains. Woods and Couchman
have demonstrated that syndecan 4 is a component of focal
adhesions of fibroblasts on ECM substratum [10]. These authors
observed that this morphological colocalization is of functional
relevance. Syndecan 4 is the cell surface proteoglycan which is
necessary to enable kidney fibroblasts to form focal adhesions
after binding to one of fibronectin's heparin-binding domains.
This interaction may trigger the activity of protein kinase C, the
inhibition of which completely prevents formation of focal adhe-
sions. Obviously, studies with respect to the potential presence or
function of such surface proteoglycans on MCs are of consider-
able interest.
Signaling by integrins
At present, there is limited information on mechanisms by
which ECM-integrin interactions affect behavior of glomerular
cells. In this regard, much more research has been performed
using polarized epithelial cells or fibroblasts and vascular smooth
muscle cells. These observations have clearly demonstrated that
integrins are able to transduce biochemical signals across the cell
membrane to the cell interior, leading to changes in gene expres-
sion and cellular phenotype. For example, integrins have been
shown to regulate diverse intracellular signaling pathways, includ-
ing intracellular pH and Ca2 levels, tyrosine phosphorylation
and induction of transcription factors [reviewed in 11.
Recent cell culture studies have greatly advanced our knowl-
edge on the organization of components involved in specific
interactions of an ECM ligand with a cell surface receptor and
subsequent cellular transducers. Many cell types, mainly of me-
sodermal origin, including fibroblasts, vascular smooth muscle
cells and MCs, when plated on matrix substratum form transmem-
branous assemblies, which are known as focal contacts or focal
adhesions. Focal contacts allow cells to anchor to their environ-
ment and may thus facilitate not only cell and tissue organization
but also the exertion of tension, such as in contraction, wound
closure, etc. As shown schematically in Figure 1, the ECM ligand
leads to clustering of adjacent integrins and formation of a focal
contact. Indeed, the localization of certain integrin a-chains into
focal contacts depends on the specific ECM ligand. For example,
use of fibronectin as substratum, which is abundant in the
mesangial matrix, induces the movement of a5f31 integrin but not
of a4f31 or a6f31 into focal contacts of MCs [12, 13]. Laminin
interacts with focal contacts containing a1 131, a2f31, or a3131, [12,
14] (Table 3). Hence, on MCs, laminin does not appear to use its
specific surface receptor, a6131, but promiscuous a-chains.
Beside clustered integrins, the cytoplasmatic plaque of a focal
contact contains a complex of intracellular cytoskeletal proteins,
including paxillin, talin, a-actinin, tensin and vinculin. These and
other cytoskeletal components provide linkage to actin microfila-
ment bundles, important for cell shape change, contraction and
motility. While the cytoplasmatic domains of the a and /3 integrin
chains do not have any intrinsic enzymatic activity, the focal
contact assembly also contains multiple regulator molecules, such
as tyrosin kinases and protein kinase C (PKC). It has been shown
that the PKC isoform, PKCa, is a focal adhesion component in
several cell types. A cytoplasmatic protein tyrosine kinase, termed
focal adhesion kinase (FAK), is involved in the signal transduction
pathways initiated by ligand-integrin binding on the cell surface.
FAK is rapidly phosphorylated and activated following attach-
ment of fibroblasts to fibronectin-coated surfaces or integrin
clustering by antibodies [15]. FAK has been localized to focal
contacts, consistent with its role in initiating the signaling cascade
following ligand-integrin interaction [16].
Recent data have also demonstrated that fibronectin binding to
integrins promotes SH2 domain-mediated association of the
GRB2 adapter protein and the c-src protein tyrosine kinase with
FAK in vivo, and also results in activation of mitogen-activated
Fig. 2. Focal contacts of cultured human
mesangial cells shown by immunofluorescence
microscopy. Double-labeling of MCs for talin
(left) and integrin a2-chain (right). While talin
is localized prominently to focal contacts of
MCs grown on all ECM components used, 02
localized strongly on collagen I, moderately on
laminin (murine) and only very weakly on
fibronectin, indicating the specific nature of
focal contact organization (X200).
Photomicrographs were provided by H. Grenz,
University Erlangen-Nurnberg.
protein kinase (MAPK) [17]. Phosphatidylinositol 3-kinase was
shown to be a substrate of FAK in vivo and may also serve as an
effector of FAK [18]. In addition, integrin-mediated fibronectin
attachment to fibroblasts and smooth muscle cells caused an
increase in the activity of the transcription factor NF-iB, although
a direct involvement of FAK remains to be demonstrated [191.
Taken together, these data indicate that signal transduction
events are elicited by interaction of insoluble ECM ligands with
integrins and integrin-mediated FAK phosphorylation which are
similar to those stimulated by binding of soluble growth factors to
receptor tyrosine kinases.
Mesangial cell functions regulated by cell-matrix interactions
Maintenance of structural and functional integrity of
glomerular tuft
The mesangial matrix is characterized by the presence of small
bundles of fine fibers. These microfibrils form an extensively
interwoven three-dimensional meshwork which also provides an
array of contacts between MCs and the perimesangial GBM.
Fibronectin, the most abundant molecule in the mesangial matrix
has been shown to be associated with microfibrils and may serve
to link MC surfaces to these extracellular structures. Therefore,
ECM molecules are thought to function as stabilizers of the
three-dimensional architecture of the glomerular capillary tuft,
counteracting the distending forces (hydraulic pressure gradient
across the capillary wall) acting on the GBM by transmitting
inward directed traction generated by contractile MCs. It has been
speculated that loss of the ECM linkage of MCs to the GBM may
cause the development of glomerular capillary microaneurysms
[20, 21], since basement membranes are no longer held in a fixed
position by their attachment to the mesangium.
Owing to their location, MCs are subjected to pulsatile stretch
and relaxation cycles resulting from changes in intravascular
hydraulic pressure. To investigate this effect of mechanical strain
on cultured MCs, flexible culture surfaces have been used which
allow cell growth in a pulsatile environment, where stretch-
relaxation cycles are regulated by computer-driven devices. Cyclic
stretching altered cell morphology, stimulated MC proliferation
and increased the production of laminin, fibronectin, type I, III,
IV collagen [22]. Increased MC elongation was found to be
directly related to increased type IV collagen expression. The
expression of type IV collagenase mRNA was unchanged or
slightly decreased [22]. Based on such findings, it has been
proposed that increased ECM deposition, as seen in states of
glomerular hypertrophy, could be in part due to greater physical
forces acting on MCs with consecutive alterations in ECM
synthesis profile. However, the exact mechanisms, how increased
glomerular capillary pressure could be translated into mesangial
ECM accumulation have yet to be clarified.
Dynamic regulation of MC adhesion
Anchorage-dependent cells require attachment to ECM to
allow expression of a differentiated phenotype as well as growth.
Various ECM molecules have been shown to serve as adhesive
substrates for MCs in vitro (Fig. 2 and Table 3). Initial ECM-
integrin interaction and MC attachment is followed by cell
spreading and subsequent organization of focal contacts [12]. The
process of specific attachment of MCs to ECM molecules is
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regulated in a complex and dynamic manner. During prolifera-
tion, adhesive forces have to be diminished to allow rounding and
division of cells. While focal contacts of fibroblasts appear to be
instrumental for contraction and tension generation to direct
wound closure in vivo, it is unclear whether MCs exert tension on
their surrounding matrix and the capillaries, such as following a
glomerular lesion.
At present, little is known which factors control adhesion of
MCs to matrix. As discussed above, multiple ECM molecules,
notably fibronectin, collagens and laminin specifically interact
with MC integrins and induce formation of focal adhesion sites.
Other ECM glycoproteins, including thrombospondin, SPARC
(also termed osteonectin) and tenascin, can antagonize the adhe-
sive process. These latter compounds appear to serve anti-
adhesive functions promoting cell rounding and partial detach-
ment of cells from the substratum [23]. In addition, SPARC has
been demonstrated to inhibit progression through the cell cycle in
vitro [231. While these glycoproteins are secreted and retained in
the local environment where they can function in an autocrine or
paracrine manner, they usually do not function as structural
components. A recent immunohistochemical study indicated that
tenascin is a component of the mesangial matrix in the normal
mature human kidney [24]. In biopsies from diseased kidneys it
was noted that, whenever there was expansion of mesangial ECM,
there was a concomitant and proportional increase in the pres-
ence of tenascin. It remains unclear from this descriptive work,
however, whether tenascin or other anti-adhesive ECM molecules
play a protective or detrimental role in the evolution of glomer-
ular diseases. More specifically, it remains to be clarified whether
and how glycoproteins may influence MC adhesiveness and,
possibly, proliferation in glomerular disease.
The formation of focal contacts involving expression of integrin
receptors is likely to be also affected by soluble regulators. First
studies have shown that TGF-13, EGF and HGF can affect focal
contact formation and/or components of integrin signal transduc-
tion pathways in different cell types [25, 26]. Clearly, much more
information is required to better understand these aspects of
cooperative regulation of cell behavior by soluble growth factors
and ECM.
ECM molecules and growth regulation
Growth of MCs is controlled by many soluble regulator mole-
cules. Among them are various cytokines, growth factors, auta-
coids and hormones. In the last decade, experimental evidence in
different cell systems has revealed that the ECM can also modu-
late cell growth as well as ECM synthesis. For example, MCs
cultured on collagen type IV and laminin exhibit increased
production and secretion of fibronectin and laminin [27]. In vitro,
freshly seeded MCs do not only plate with much higher efficiency
on collagen types I, II and IV compared to plastic but also show
greater replication activity [28]. Thrombospondin increases MC
proliferation, an effect that might be mediated by up-regulation of
EGF and PDGF secretion [29]. Heparan sulfate proteoglycan
influences cell behavior in a different manner. Recently, we
observed that the rapid attachment of MCs to fibronectin is
greatly inhibited by the heparan sulfate proteoglycan, perlecan
(Gauer, Schulze-Lohoff and Sterzel, unpublished observation).
Also, Groggel et al have reported dose-dependent inhibition of
MC proliferation by heparan sulfate in culture [30]. This effect is
in keeping with the recent finding that some proteoglycans are
able to bind and sequester various cytokines. The proteoglycan
decorin, for example, the production of which is increased in MCs
by TGF-f3, was shown to neutralize the action of TGF-f3. This
effect could reflect an autoregulatory feedback system. Further-
more, bFGF strongly binds to heparan sulfate proteoglycans.
Since bFGF has been reported to influence experimental kidney
diseases, this could represent an important regulatory function of
basement membrane proteoglycans. In a recent study, Morita and
co-workers demonstrated that heparan sulfate proteoglycans
show enrichment of bFGF-binding domains in fibrotic lesions of
the peritubular interstitium [31]. Taken together, these reports
demonstrate the important function of ECM molecules to bind
and sequester growth factors, possibly providing a local "reser-
voir" of regulatory proteins and presenting them to adjacent cells
in a biologically more active form, when needed.
The concept of interdependency of MC growth and ECM
synthesis and secretion by MCs has also been supported by the
finding that production of collagens, fibronectin and laminin
paralleled proliferation of cultured MCs [27]. Of note, localiza-
tion of ECM constituents was strictly intracellular until confluency
of MCs with cell-cell contacts was reached, when extracellular
deposition of collagen IV and laminin appeared, followed by
collagen I and fibronectin. On surfaces coated with the GBM
components collagen IV and laminin, secretion and extracellular
matrix deposition of ECM preceded confluency [27]. Thus, pro-
duction and distribution of ECM is affected not only by MC
growth but also by cell-cell contact and composition of ECM
already deposited.
Parallel increases of MC proliferation and ECM formation
have been observed in several in vivo models of glomerular
disease. In rat anti-Thy 1.1 glomerulonephritis, Floege et al
demonstrated an increase of ECM synthesis during proliferation
of MCs [32]. Similar results were obtained in the remnant kidney
model and in focal glomerular sclerosis induced by puromycin
aminonucleoside.
However, MC growth and ECM synthesis are not necessarily
influenced in a concordant manner. Several groups have demon-
strated that cultured MCs, incubated under high glucose condi-
tions, markedly increased synthesis of various ECM components
(laminin, fibronectin, collagen types IV and VI, and inconsis-
tently, collagen type I), whereas proliferation was found to be
inhibited [33]. In a recent study it was shown that the stimulation
of fibronectin synthesis by high glucose in cultured MCs closely
correlated with the inhibition of MC proliferation. Evidence has
been provided that this effect is mediated by the activation of
protein kinase C [34]. The degree of glycation of matrix molecules
also influences MC behavior, Cultured MCs adhered less effec-
tively to glycated collagen type IV and were delayed in attaining
maximal levels of adhesion compared to cells interacting with
control collagen [35].
Taken together, there is ample evidence, albeit mostly based on
MC culture studies, that mesangial ECM does not only act as a
mechanical, inert structural support system of the glomerular
capillary tuft. Rather, it has become clear that ECM affects and
regulates cellular events in a specific manner, similar to growth
factors and cytokines. ECM molecules are able, via interaction
with specific receptors, to influence many aspects of MC behavior,
like adhesion and growth, migration, differentiation, repair and
possibly apoptosis [36].
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ECM organization and MC differentiation
Based on the evidence of studies on MCs as well as renal
epithelial cells and fibroblasts (notably during embryogenesis and
organ development), the ECM-mediated effects on the MC
phenotype have to be considered as part of a cooperative control
system which also involves the action of soluble regulators and
MC interaction with adjacent endothelial as well as infiltrating
cells (Fig. 3). The spatial organization and composition of the
ECM constitutes a regulated microenvironment of MCs in the
glomerulus, thus providing a non-soluble context which, as such, is
likely to affect the regulation of the MC phenotype by soluble
factors. In this regard, it is important to stress that effects of ECM
on MCs in vivo or in three-dimensional (3-D) culture may differ
significantly from a situation when MCs grown in a monolayer on
a two-dimensional ECM substratum or on plastic. For example,
MCs grown in 3-D culture in collagen gels show reduced prolif-
erative activity and a metabolically active and differentiated
phenotype [371 This appears to more closely resemble non-
polarized, differentiated MCs found in the normal kidney, as
compared to the proliferating MC phenotype maintained in 2-D
culture in the presence of fetal calf serum.
In this context it is of interest that MCs in long-term culture
form multilayers and round protrusions, or hillocks, which are
nodules of MCs embedded in a supporting 3-D meshwork of
ECM [381 (Fig. 4). In the periphery of hillocks, the morphologic
MC phenotype is fusiform and elongated while it is stellate and
plump in hillock centers. In labeling studies, the central, stellate
and more differentiated MC phenotype was found to be down-
regulated with regard to DNA replication but showed high
secretory activity producing collagens I and III as well as fibronec-
tin (Grond, Sterzel and Kashgarian, unpublished observations). It
is as yet unclear which factors regulate the maintenance of MC
differentiation under 3-D culture conditions as well as in vivo.
Also, data on differential expression of ECM receptors on MCs
grown in 3-D as compared to 2-D culture are lacking. Thus, the
role and mechanism of interactions between 3-D ECM and MCs
in the regulation of the observed cellular phenotypes remains to
be clarified.
ECM in glomerular repair processes
While the abnormal mesangial ECM deposition in glomerular
disease has been described in great detail, few data exist concern-
ing ECM involvement in repair mechanisms regulating recovery
from injury and restoring structural and functional integrity of the
glomerulus. Resolution of abnormal ECM accumulation has to
involve modification of ECM turnover targeting the balance of
ECM deposition and proteinase secretion and activity. It is
presently unclear, however, whether interaction of glomerular
cells with the mesangial ECM may play a regulatory role in the
resolution of glomerular disease.
A novel aspect concerning resolution of glomerular pathology
points towards a possible role of MC-matrix interactions in the
induction of apoptosis in the recovery phase of glomerulone-
phritic disease. The interdependency of MC proliferation and
increased ECM synthesis has been demonstrated in several ex-
perimental rat models, including anti-Thy 1.1 glomerulonephritis,
the remnant kidney model and focal glomerular sclerosis induced
by puromycin aminonucleoside. Baker et a! demonstrated MC
apoptosis to be a major cell clearance mechanism counterbalanc-
ing cell division in the self-limited anti-Thyl glomerulonephritis,
thereby mediating resolution of glomerular hypercellularity in
experimental mesangial proliferation [391.Induction of apoptosis,
however, may be dependent on and regulated by the expression of
distinct sets of cell adhesion molecules. Recently, Zhang et a!
demonstrated in CHO cells that expression of a5/31-integrin, but
not of the closely related a1-integrin, which binds fibronectin on
the same RGD motif, appears to suppress apoptosis through the
bcl-2 pathway [361. Thus, one could hypothesize that integrin-
mediated signaling regulates induction of apoptosis in vivo and
may thereby contribute to glomerular repair processes. Clearly,
1580 Rupprecht et al: Cell-matrix interactions
Fig. 3. Control of cellular responses by
interactions between cells, extracellular matrix and
soluble mediators. Abbreviations are: bFGF,
basic flbroblast growth factor; PDGF, platelet-
derived growth factor; TGF-j3, transforming
growth factor beta.
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Fig. 4. Hillocks of cultured rat mesangial cells. (A) Phase contrast micro-
graph of several hillocks protruding from confluent MCs (X60). (B)
Section of isolated hillock transferred to filter for further growth. Sparsely
scattered MCs seen in central portion, consisting of ECM masses, and rim
of elongated MCs in the periphery of hillock (H&E, x 100). Photomicro-
graphs were kindly provided by Dr. Joris Grond, University of Groningen,
Netherlands.
this field of research requires much work to help elucidate the role
of ECM and ECM receptors in resolution and repair after
glomerular injury.
Mesangial matrix in the pathogenesis of glomerulonephritis
In addition to many reports on the deposition and turnover of
ECM in cultured MCs, several recent studies have analyzed the
accumulation of mesangial ECM in a variety of experimental
models of glomerular disease. These results are mostly descrip-
tive, investigating composition and synthesis of ECM by immuno-
histochemistry and gene expression by Northern blot analysis in
renal ablation models, experimental mesangial proliferative ne-
phritis, chronic purine aminonucleoside nephrosis [40], experi-
mental membranous nephropathy, murine graft-versus-host dis-
ease, and streptozotocine-induced diabetic nephropathy (Table
1). In addition, Isaka et a! have recently demonstrated increased
ECM accumulation after liposome-mediated gene transfer of
TGF-!3 to the glomerulus [41]. Kagami et al demonstrated in the
anti-Thy ii model of mesangioproliferative glomerulonephritis
that there is not only increased synthesis of ECM molecules, but
also coordinated glomerular expression of a1 13! and cs5131-inte-
grins with laminin, collagen and fibronectin, the ligands for these
receptors.
Since in vitro studies have demonstrated tight regulation of
mesangial ECM synthesis by (i) cytokine-mediated signals, (ii)
mitogenesis, (iii) metabolic factors, and (iv) mechanical stress,
several in vivo studies have been designed to modulate these
potentially pathogenetic factors targeting control of mesangial
ECM deposition in experimental animal models. Relevant obser-
vations of such investigations include: (i) Application of neutral-
izing antibody to TGF-p or application of decorin, a natural
inhibitor of TGF-p, beginning at the time of induction of the
anti-Thy 1.1 model, suppressed production of ECM and signifi-
cantly attenuated histological manifestation of scarring glomeru-
lar disease [42]. (ii) Inhibition of MC proliferation in the anti-Thy
1.1 model of glomerulonephritis by administration of neutralizing
PDGF antibodies or heparin [431 was also shown to reduce
mesangial ECM deposition. (iii) Dietary protein restriction has
been shown to reduce TGF-p expression and mesangial ECM
accumulation in the anti-Thy 1.1 model and the PAN model of
glomeruloscierosis. (iv) Synthesis of fibronectin by isolated gb-
meruli from 5/6-nephrectomized hypertensive rats was suppressed
in animals on antihypertensive therapy with the ACE-inhibitor
enalapril.
These initial studies have demonstrated certain indirect ap-
proaches to inhibit or diminish the accumulation of mesangial
ECM. While they help to develop and test new research tools,
much more information needs to be gathered to allow better
understanding of the pathogenic mechanisms leading to glomer-
uloscierosis, including aberrant as well as protective cell-matrix
interactions in the mesangium. Such information is required for
rational, specific and effective treatment and prevention of mes-
angial ECM build-up seen in progressive glomerular disease
leading to irreversible loss of renal structure and function.
Acknowledgments
Research data used for this review were obtained with the support of
the Deutsche Forschungsgemeinsehaft, Bonn; Klinische Forschergruppe
Ste 196/3 to 1 and Sonderforschungsbereich 263/B5. The secretarial help
of Ms. Christine Meister is gratefully recognized. Dr. Manfred Ziegenha-
gen provided valuable help with literature search and discussion.
Reprint requests to Prof Dr. R.B. Ste,zel, Medizinische Klinik IV, tlniver-
sildt Erlangen-Nflrn berg, Krankenhausstrasse 12, 91054 Erlangen, Germany.
References
1. ABPASS CK, ADCOX MJ, RAUG! GJ: Aging-associated changes in renal
extracellular matrix. Am J Pathol 146:742—752, 1995
2. STERZEL RB, SCHULZE LOHOFF E, WEBER M, GOODMAN SL: Inter-
actions between gbomerular mesangial cells, cytokines, and extracel-
lular matrix. JAm Soc Nephrol 2:S126—S131, 1992
3. PUGLIESE G, PR!CC! F, PUGL!ESE F, MENE P, LENT! L, ANDREANI D,
GALI.I G, CA5INI A, BIANCHI 5, ROTELLA CM: Mechanisms of
glucose-enhanced extracellular matrix accumulation in rat gbomerular
mesangial cells. Diabetes 43:478—490, 1994
1582 Rupprecht et al: Cell-matrix interactions
4. ZIYADEH FN, SI-IARMA K, ERICKSEN M, WOLF Ge Stimulation of
collagen gene expression and protein synthesis in murine mesangial
cells by high glucose is mediated by autocrine activation of transform-
ing growth factor-beta. J Clin Invest 93:536—542, 1994
5. TAMSMA JT, VAN DEN BORN J, BRUIJN JA, ASSMANN KJ, WEaNING JJ,
BERDEN JH, WIESLANDER J, SCHRAMA E, HERMANS J, VEERKAMP JH,
LEMKES HHPJ, VAN DER WOUDE FJ: Expression of glomerular
extracellular matrix components in human diabetic nephropathy:
Decrease of heparan sulphate in the glomerular basement membrane.
Diabetologia 37:313—320, 1994
6. DAVIES M, MARTIN J, ThOMAS GJ, LOVErr DH: Proteinases and
glomerular matrix turnover. Kidney mt 41:671—678, 1992
7. HAGEGE J, PERALDI MN, RONDEAU E, ADIDA C, DELARUE F,
MEDCALF R, SCHLEUNING WD, SRAER JD: Plasminogen activator
inhibitor-i deposition in the extracellular matrix of cultured human
mesangial cells. Am J Pathol 141:117—128, 1992
8. MARTI HP, MCNEIL L, DAVIES M, MARTIN J, LOvErr DH: Homology
cloning of rat 72 kD type IV collagenase: cytokine and second-
messenger inducibility in glomerular mesangial cells. Biochem J
291:441—446, 1993
9. LOVE-I-F DH, JOHNSON RJ, MARTI HP, MARTIN J, DAVIES M, COUSER
WG: Structural characterization of the mesangial cell type IV colla-
genase and enhanced expression in a model of immune complex-
mediated glomerulonephritis. Am J Pathol 141:85—98, 1992
10. WooDs A, COUCHMAN JR: Syndecan 4 heparan sulfate proteoglycan is
a selectively enriched and widespread focal adhesion component. Mol
Biol Cell 5:183—192, 1994
11. JULIANO RL, HASKILL S: Signal transduction from the extracellular
matrix. J Cell Biol 120:577—585, 1993
12. PETERMANN A, FEES H, GRENZ H, GOODMAN SL, STERZEL RB:
Polymerase chain reaction and focal contact formation indicate
integrin expression in mesangial cells. Kidney mt 44:997—1005, 1993
13. CoSlo FG, SEDMAK DD, NAHMAN NSJ: Cellular receptors for matrix
proteins in normal human kidney and human mesangial cells. Kidney
mt 38:886—895, 1990
14. ADLER S: Integrin receptors in the glomerulus: potential role in
glomerular injury. (editorial) Am J Physiol 262:F697—F704, 1992
15. HANKS SK, CALALB MB, HARPER MC, PATEL SK: Focal adhesion
protein-tyrosine kinase phosphorylated in response to cell attachment
to fibronectin. Proc NatI Acad Sci USA 89:8487—8491, 1992
16. PARSONS JT, SCHALLER MD, HILDEBRAND 3, LEU TH, RICHARDSON A,
OTEY C: Focal adhesion kinase: Structure and signalling. J Cell Sci
Suppl 18:109—113, 1994
17. SCHLAEPFER DD, HANKS SK, HUNTER T, v.r' DER GEaR P: Integrin-
mediated signal transduction linked to Ras pathway by GRB2 binding
to focal adhesion kinase. Nature 372:786—791, 1994
18. CHEN HC, GUAN JL: Association of focal adhesion kinase with its
potential substrate phosphatidylinositol 3-kinase. Proc NatI Acad Sci
USA 91:10148—10152, 1994
19. QWARNSTROM EE, OSTBERG CO, TURK GL, RICHARDSON CA,
BOMSZTYK K: Fibronectin attachment activates the NF-kappa B
p5O/p65 heterodimer in fibroblasts and smooth muscle cells. J Biol
Chem 269:30765—30768, 1994
20. COUCHMAN JR, BEAVAN LA, MCCARTHY KJ: Glomerular matrix:
Synthesis, turnover and role in mesangial expansion. Kidney mt
45:328—335, 1994
21. DAVIES Me The mesangial cell: A tissue culture view. Kidney mt
45:320—327, 1994
22. HARRIS RC, AKAI Y, YASUDA T, HOMMA T: The role of physical
forces in alterations of mesangial cell function. Kidney Int 45(Suppl
45):S17—S21, 1994
23. LANE TF, SAGE EH: The biology of SPARC, a protein that modulates
cell-matrix interactions. FASEB J 8:163—173, 1994
24. TRUONG LD, PINDUR 3, BARRIOS R, D'AGATI V, LECHAGO J, SUKI W,
MAJESKY M: Tenascin is an important component of the glomerular
extracellular matrix in normal and pathologic conditions. Kidney mt
45:201—210, 1994
25. CLARK EA, BRUGGE JS: Integrins and signal transduction pathways:
The road taken. Science 268:233—239, 1995
26. BRUIJN JA, DE HEER E: Adhesion molecules in renal diseases. Lab
Invest 72:387—394, 1995
27. ISI-IIMURA E, STERZEL RB, BUDDE K, KASHGARIAN M: Formation of
extracellular matrix by cultured rat mesangial cells. Am J Pathol
134:843—855, 1989
28. SIMONSON MS, CULP LA, DUNN MJ: Rat mesangial cell-matrix
interactions in culture. Exp Cell Res 184:484—498, 1989
29. MARINIDES GN, SUCHARD SJ, MOOKERJEE BK: Role of throm-
bospondin in mesangial cell growth: Possible existence of an autocrine
feedback growth circuit. Kidney mt 46:350—357, 1994
30. GROGGEL GC, MARINIDES GN, HOVINGH P, HAMMOND E, LINKER A:
Inhibition of rat mesangial cell growth by heparan sulfate. Am J
Physiol 258:F259—F265, 1990
31. MORITA H, SHINZATO T, DAVID G, MIZUTANI A, HABUCHI H, FUJITA
Y, ITO M, ASAI 3, MAEDA K, KIMATA K: Basic fibroblast growth
factor-binding domain of heparan sulfate in the human glomerulo-
sclerosis and renal tubulointerstitial fibrosis. Lab Invest 71:528—535,
1994
32. FLOEGE 3, JOHNSON Ri, GORDON K, IIDA H, PRITZL P, YOSHIMURA A,
CAMPBELL C, ALPERS CE, COUSER WG: Increased synthesis of
extracellular matrix in mesangial proliferative nephritis. Kidney Int
40:477—488, 1991
33. Ao SH, RADNIK RA, GLASS WF, GARONI JA, RAMPT ER, APPLING
DR, KREISBERG 31: Increased extracellular matrix synthesis and
mRNA in mesangial cells grown in high-glucose medium.AmJPhysiol
260:F185—F191, 1991
34. Coo FO: Effects of high glucose concentrations on human mesangial
cell proliferation. JAm Soc Nephrol 5:1600—1609, 1995
35. ANDERSON SS, KIM Y, TSILIBARY EC: Effects of matrix glycation on
mesangial cell adhesion, spreading and proliferation. Kidney Int
46:1359—1367, 1994
36. ZHANG Z, VUORI K, REED JC, RUOSLAHTI E: The a5f31 integrin
supports survival of cells on fibronectin and upregulates bcl-2 expres-
sion. Proc NatlAcad Sci USA 92:6161-6165, 1995
37. MARX M, DANIEL TO, KASHGARIAN M, MADRI JA: Spatial organiza-
tion of the extracellular matrix modulates the expression of PDGF-
receptor subunits in mesangial cells. Kidney Int 43:1027—1041, 1993
38. STERZEL RB, LOVE-IT DH, FOELLMER HG, PERFETI'O M, BIEMESDER-
FER D, KASI-IGARIAN Me Mesangial cell hillocks: Nodular foci of
exaggerated growth of cells and matrix in prolonged culture. Am J
Pathol 125:130—140, 1986
39. BAKER AJ, MOONEY A, HUGHES 3, LOMBARDI D, JOHNSON RJ, SAVILL
3: Mesangial cell apoptosis: The major mechanism for resolution of
glomerular hypercellularity in experimental mesangial proliferative
nephritis. J Clin Invest 94:2105—2116, 1994
40. JONES CL, BUCH S, POST M, MCCULLOCH L, LIU E, EDDY AA: Renal
extracellular matrix accumulation in acute puromycin aminonucleo-
side nephrosis in rats. Am J Pathol 141:1381—1396, 1992
41. I5AKA Y, FUJIWARA Y, UEDA N, KANEDA Y, KAMADA T, IMAI E:
Glomeruloscierosis induced by in vivo transfection of transforming
growth factor-beta or platelet-derived growth factor gene into the rat
kidney. J Cliii Invest 92:2597—2601, 1993
42. BORDER WA, NOBLE NA, YAMAMOTO T, HARPER JR, YAMAGUCHI Y,
PIERSCHBACHER MD, RUOSLAHTI E: Natural inhibitor of transforming
growth factor-p protects against scarring in experimental kidney
disease. Nature 360:361—364, 1992
43. FLOEGE 3, ENG E, YOUNG BA, COUSER WG, JOHNSON Ri: Heparin
suppresses mesangial cell proliferation and matrix expansion in ex-
perimental mesangioproliferative glomerulonephritis. Kidney Int 43:
369—380, 1993
